Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
Biotech ETF Index Surges 10% After Rebalance
3 Under-the-Radar Stocks to Buy and Hold for a Decade
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million
First Look: Meta cuts, Intel beats, oil jumps, Apple shift
Rtw Investments, Lp Acquires 500,000 Shares of Kailera Therapeutics (NASDAQ:KLRA) Stock
Kailera Therapeutics' Strong IPO Validates "NewCo" Strategy
First Look: Tesla beats, WBD vote, oil near $100, AI moves
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race
Kailera Therapeutics Announces Pricing of Initial Public Offering
Kailera Therapeutics Pursues IPO On Promising GLP-1 Trial Results
Kailera Therapeutics files for US IPO